ABSTRACT
Background Fixed-effect meta-analysis has been used to summarize genetic effects on a phenotype across multiple Genome-Wide Association Studies (GWAS) assuming a common underlying genetic effect. Genetic effects may vary with age, therefore meta-analysing GWAS of age-diverse samples could be misleading. Meta-regression allows adjustment for study specific characteristics and models heterogeneity between studies. The aim of this study was to explore the use of meta-analysis and meta-regression for estimating age-varying genetic effects on phenotypes.
Methods With simulations we compared the performance of meta-regression to fixed-effect and random -effects meta-analyses in estimating (i) main genetic effects and (ii) age-varying genetic effects (SNP by age interactions) from multiple GWAS studies under a range of scenarios. We applied meta-regression on publicly available summary data to estimate the main and age-varying genetic effects of the FTO SNP rs9939609 on Body Mass Index (BMI).
Results Fixed-effect and random-effects meta-analyses accurately estimated genetic effects when these did not change with age. Meta-regression accurately estimated both the main genetic effects and the age-varying genetic effects. When the number of studies or the age-diversity between studies was low, meta-regression had limited power. In the applied example, each additional minor allele (A) of rs9939609 was inversely associated with BMI at ages 0 to 3, and positively associated at ages 5.5 to 13. This is similar to the association that has been previously reported by a study that used individual participant data.
Conclusions GWAS using summary statistics from age-diverse samples should consider using meta-regression to explore age-varying genetic effects.
KEY MESSAGES
Meta-analysis has been used to summarize genetic effects on a phenotype across multiple Genome-Wide Association Studies (GWAS) assuming a common underlying genetic effect for all studies. However, genetic effects may vary with age, therefore meta-analysing GWAS of age-diverse samples could produce misleading results.
Meta-regression could be used to relate observed between-study heterogeneity to study characteristics such as age. Therefore, meta-regression could be used to combine summary level GWAS data to provide evidence for any age-varying genetic effects.
This simulation study shows that when genetic effects vary with age, meta-regression provides unbiased estimates of main and age-varying genetic effects. The precision of the estimates depends on the number of studies included, and the diversity in age between them.
The applied example using publicly available summary data, supported the simulation study.
By applying meta-regression, we observed a previously reported age-varying association between each additional minor allele (A) of rs9939609 and BMI; an inverse at ages 0 to 3 and a positive association at ages 5.5 to 13.Similar association has been previously reported by a study that used individual participant data.
Competing Interest Statement
DAL has received support in the last 10-years from Medtronic Ltd and Roche Diagnostics for research unrelated to that presented here. The other authors declare no conflict of interest.
Funding Statement
PP, DAL, ES, KT & TM receive funding from the University of Bristol and the UK Medical Research Council (grant reference: MC_UU_00011/1, MC_UU_00011/3 and MC_UU_00011/6). JPTH (NF-SI-0617-10145) and DAL (NF-0616-10102) are NIHR Senior Investigators and are both supported by the NIHR Bristol Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. JPTH is also supported by the NIHR Applied Research Collaboration West (ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust. DALs contribution to this paper is further supported by the British Heart Foundation (CH/F/20/90003 and AA/18/7/34219). NMW is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Grant (grant reference: 2008723). This work was carried out using the computational facilities of the Advanced Computing Research Centre, University of Bristol - http://www.bristol.ac.uk/acrc/.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Summary data used in the applied example can be found in the original publication (10.1371/journal.pgen.1001307).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† Joint last authors
Data Availability
The code used in this simulation study will become available at publication. All data produced in the present work are contained in the manuscript.
